A phase I/II study of induction oxaliplatin, 5FU chemoradiation in patients with locally advanced, unresectable pancreatic cancer

被引：0
|
作者：
Leung, R. C. [1 ]
Ryan, T. [1 ]
Hochster, H. [1 ]
Newman, E. [1 ]
Chandra, A. [1 ]
机构：
[1] NYU, Med Ctr, New York, NY 10016 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15027
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Can we downstage locally advanced pancreatic cancer to resectable? A phase I/II study of induction oxaliplatin and 5-FU chemoradiation
    Amodeo, Salvatore
    Masi, Antonio
    Melis, Marcovalerio
    Ryan, Theresa
    Hochster, Howard S.
    Cohen, Deirdre J.
    Chandra, Anurag
    Pachter, H. Leon
    Newman, Elliot
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (05) : 922 - 935
  • [2] PHASE II STUDY OF PREOPERATIVE OXALIPLATIN AND 5FU WITH CONCURRENT RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
    Chao, M.
    Field, K.
    McLaughlin, S.
    Jones, I
    Hayes, I
    Faragher, I
    Skinner, I
    Gibbs, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 108 - 108
  • [3] Can We Downstage Regionally Advanced Pancreatic Cancer to Resectable: A Phase I/II Study of Induction Oxaliplatin and 5FU Chemo-Radiation
    Melis, Marcovalerio
    Ryan, Theresa
    Hochster, Howard S.
    Cohen, Deirdre
    Masi, Antonio
    Chandra, Anurag
    Pachter, H. Leon
    Newman, Elliot
    GASTROENTEROLOGY, 2011, 140 (05) : S1020 - S1020
  • [4] Concomitant administration of weekly oxaliplatin, 5FU continuous infusion and radiotherapy in locally advanced pancreatic cancer (LAPC):: A GERCOR phase II study
    Moureau-Zabotto, L.
    Phelip, J.
    Afchain, P.
    Mineur, L.
    Andre, T.
    Vendrely, V.
    Lledo, G.
    Dupuis, G.
    Touboul, E.
    Balosso, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S173 - S174
  • [5] Concomitant administration of weekly oxaliplatin, 5FU continuous infusion and radiotherapy in locally advanced pancreatic cancer (LAPC):: A GERCOR phase II study.
    Moureau-Zabotto, L.
    Phélip, J.
    Afchain, P.
    Mineur, L.
    André, T.
    Vendrely, V.
    Lledo, G.
    Dupuis, O.
    Touboul, E.
    Balosso, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 188S - 188S
  • [6] A unicentric phase II study of oxaliplatin (OXA), 5-fluorouracil (5FU) and concomitant preoperative irradiation in patients with locally advanced rectal cancer
    Marcuello, Eugenio
    Nadal, R.
    Capdevila, J.
    Garriga, J.
    Petriz, L.
    Sancho, F. J.
    Pernas, J. A.
    Gonzalez Juan, D.
    Targarona, E.
    Diez, O.
    ANNALS OF ONCOLOGY, 2006, 17 : 283 - 283
  • [7] A phase I study of oxaliplatin (OXA), 5-fluorouracil (5FU) and concomitant preoperative irradiation in patients with locally advanced rectal cancer.
    Balart, J
    Marcuello, E
    Garriga, J
    Pernas, J
    Sancho, F
    González, D
    Pétriz, L
    Llaurado, J
    Martínez, A
    Guallar, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 304S - 304S
  • [8] Phase I study of neoadjuvant 5-fluorouracil (5FU) chemoradiation (CRT) and trametinib in patients with locally advanced rectal cancers (LARC)
    Wu, Christina Sing-Ying
    Williams, Terence M.
    Wei, Lai
    Umar, Hamida
    Mikhail, Sameh
    Ciombor, Kristen Keon
    Noonan, Anne M.
    Roychowdhury, Sameek
    El-Dika, Samer S.
    Krishna, Somashekar
    Upchurch, Bennie
    McCarthy, Sean T.
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Cirocco, William
    Traugott, Amber
    Bekaii-Saab, Tanios S.
    Wuthrick, Evan John
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [9] Chemoradiation with infusional 5FU and ZD1839 (gefitinib-iressa TM) in patients with locally advanced rectal cancer: a phase II trial
    Valentini, V.
    De Paoli, A.
    Gambacorta, M. A.
    Mattiucci, G. C.
    Ratto, C.
    Boz, G.
    Innocente, R.
    Rossi, C.
    Lupattelli, M.
    Doglietto, G. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S168 - S168
  • [10] Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
    Fiore, Michele
    Ramella, Sara
    Valeri, Sergio
    Caputo, Damiano
    Floreno, Barnaba
    Trecca, Pasquale
    Trodella, Luca Eolo
    Trodella, Lucio
    D'Angelillo, Rolando Maria
    Coppola, Roberto
    SCIENTIFIC REPORTS, 2017, 7
12345